A Study to Assess Safety and Efficacy of Perampanel in Indian Participants as an Adjunctive Treatment in Partial Onset Seizures With or Without Secondary Generalized Seizures in Participants With Epilepsy Aged 12 Years or Older

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

NCT00699972 ·Status: COMPLETED ·Phase: PHASE3

A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures

NCT01618695 ·Status: COMPLETED ·Phase: PHASE3

A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures

NCT01393743 ·Status: COMPLETED ·Phase: PHASE3

Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization

NCT02726074 ·Status: COMPLETED ·Phase: PHASE4

An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects

NCT02427607 ·Status: COMPLETED ·Phase: PHASE3

4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures

NCT00368472 ·Status: COMPLETED ·Phase: PHASE2

Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

NCT02736162 ·Status: COMPLETED

Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome

NCT02834793 ·Status: TERMINATED ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy

NCT04015141 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Fycompa® (Perampanel) as Add-on Therapy in Participants With Epilepsy

NCT04230044 ·Status: COMPLETED

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

NCT01161524 ·Status: COMPLETED ·Phase: PHASE2

A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures

NCT04257604 ·Status: COMPLETED

Evaluating Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

NCT00700310 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures

NCT02220972 ·Status: WITHDRAWN ·Phase: PHASE4

A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)

NCT00903786 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Zonisamide an Antiepileptic Drug as Monotherapy or Adjunctive Therapy in Treatment of Adult Patients With Partial, Generalized or Combined Seizures.

NCT01283256 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures

NCT05533814 ·Status: COMPLETED ·Phase: PHASE4

A Global, Postmarketing Observational Safety Study to Evaluate the Safety and Tolerability of Fycompa (Perampanel) as Add-on Therapy in Epilepsy Patients Aged Greater Than or Equal to 12 Years

NCT02033902 ·Status: COMPLETED

E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures

NCT00144690 ·Status: COMPLETED ·Phase: PHASE2

Perampanel in Focal Status Epilepticus

NCT04309721 ·Status: TERMINATED ·Phase: PHASE3

Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy

NCT02914314 ·Status: COMPLETED ·Phase: PHASE2

Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures

NCT02849626 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs

NCT01527006 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

NCT00433667 ·Status: COMPLETED ·Phase: PHASE3

A Multi-center RWS of Perampanel as an add-on Treatment for Epileptic Seizures in Chinese Children

NCT05274035 ·Status: UNKNOWN